Ms. Wendy Hayes is an Independent Non-Executive Director at SciClone Pharmaceuticals (Holdings) Ltd., an Independent Director at Gracell Biotechnologies, Inc., an Independent Director at iHuman, Inc., an Independent Director at Burning Rock Biotech Ltd., an Independent Director at TuanChe Ltd., a Member at The American Institute of Certified Public Accountants and an Independent Non-Executive Director at Apollomics, Inc.

She is on the Board of Directors at SciClone Pharmaceuticals (Holdings) Ltd., Gracell Biotechnologies, Inc., iHuman, Inc., Burning Rock Biotech Ltd., TuanChe Ltd. and Apollomics, Inc. Ms. Hayes was previously employed as an Independent Director by Xinyuan Real Estate Co. Ltd., an Independent Director by Mogu, Inc., a Senior Manager & Audit Partner by Deloitte & Touche Tohmatsu CPA Ltd. /Beijing/, and a Reporting Manager-SEC & U.S. GAAP by The PMI Group, Inc.

She received her undergraduate degree from the University of International Business & Economics and an MBA from Cheung Kong Graduate School of Business.